In 2026, Dis-Chem Pharmacies completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Dis-Chem Pharmacies has also provided a category-level breakdown for 3 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2026 | 2025 | 2024 | 2023-2019 |
|---|---|---|---|---|
Total Scope 1 | 11,216.68a | 10,902.233a | 12,926.086a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 109,468.246a | 135,694.323a | N/A | |
Total Scope 3 | 2,000.218a | 1,811.662a | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 4.1753a | 5.2063a | 6.8359a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2026, the total operational greenhouse gas (GHG) emissions of Dis-Chem Pharmacies amounted to 120,684.926 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2025, the total operational greenhouse gas (GHG) emissions of Dis-Chem Pharmacies decreased by 17.68%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2026, the total Scope 1 emissions of Dis-Chem Pharmacies were 11,216.68 metric tons of CO₂ equivalent (tCO₂e).a
Since 2024, Dis-Chem Pharmacies's Scope 1 emissions have decreased by 13.22%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2025), Dis-Chem Pharmacies's Scope 1 emissions increased by 2.88%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2026, Dis-Chem Pharmacies reported Scope 2 greenhouse gas (GHG) emissions of 109,468.246 tCO₂e without specifying the calculation method.a
Compared to the previous year (2025), Dis-Chem Pharmacies's Scope 2 emissions (Unspecified Calculation Method) fell by 19.33% in 2026, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2026, Dis-Chem Pharmacies reported its Scope 2 emissions using an unspecified methodology.a
In 2026, Dis-Chem Pharmacies reported 2,000.218 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2026 disclosure of Dis-Chem Pharmacies includes a breakdown across 3 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2025, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2026, Dis-Chem Pharmacies reported total Scope 3 emissions of 2,000.218 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2025), Dis-Chem Pharmacies's Scope 3 emissions increased by 10.41%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2026, Dis-Chem Pharmacies reported emissions for 3 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2026, the largest contributors to Dis-Chem Pharmacies's Scope 3 emissions were:a
In 2026, Dis-Chem Pharmacies reported Scope 1 greenhouse gas (GHG) emissions of 11,216.68 tCO₂e and total revenues of USD 2,686 millions. This translates into an emissions intensity of 4.18 tCO₂e per millions USD.a
In 2026, Dis-Chem Pharmacies reported a Scope 1 emissions intensity of 4.18 tCO₂e per millions USD. Compared to the peer group median of 1.44, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2026, Dis-Chem Pharmacies ranked 17 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Dis-Chem Pharmacies is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2026, Dis-Chem Pharmacies reported a total carbon footprint of 122,685.144 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 17.33% decrease compared to 2025, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Dis-Chem Pharmacies's total carbon footprint was Scope 2 emissions, accounting for 89.23% of the company's total carbon footprint, followed by Scope 1 emissions at 9.14%.a